Finnish outpatient and occupational healthcare specialist Mehilainen has made two acquisitions in Estonia. The company says strong expansion into Estonia is a natural next step in Mehilainen’s internationalisation strategy.
Revenues in the EMEA for-profit hospital market fell by 3-5% in 2020 due to COVID-19 but could bounce back strongly in 2021, figures from HBI Intelligence show. NMC Health CEO Michael Davis tells HBI he anticipates a ‘return to normalcy’ to continue through the year.
PE firm Triton has agreed to "invest" in Dutch, Nordic and German ambulatory clinic operator Bergman Clinics, possibly implying it is not buying control from NPM Capital and the Malensteins who are retaining stakes. Triton would not comment on the size of the stake nor on our speculation it plans to merge Bergman with Nordic operator Aleris.
HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.
Care workers in France are quitting domiciliary care in droves, and heading into the more lucrative nursing homes sector, Amir Reza, CEO of France-based domiciliary specialist Vitalliance tells HBI.
Ireland is a relatively small market, with a population of just five million, and aging demographics behind most of continental Europe. Despite this, it is attracting the interest of large nursing home groups and property funds. HBI talks to two market experts about the appeal of the Irish nursing home sector and how it will develop in the future.
The number of assisted living sites in France is expected to more than double between now and 2030, according to Les Essentielles, an assisted living-focused subsidiary of Korian. HBI speaks to their executive director, Arnaud Choulet, and to Frédéric Walther, Managing Director of Domitys, to find out more.
That the UK's COVID-hit domiciliary market has recently been hugely challenging both operationally and financially for providers is no surprise, but there is ‘light at the end of the tunnel’ with M&A increasingly back on the table, one UK-based operator tells HBI.
Bupa is replacing its ‘Global and UK’ market unit CEO David Hyman in one of the first senior changes under new group CEO Iñaki Ereño. Full-year results show flat revenue and a 4% drop in underlying profits.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.